GPR174 敌对主义:结构,功能和动力学
bioRxiv : the preprint server for biology
|September 26, 2025
概括
参与癌症免疫疗法耐药性的受体GPR174被对抗剂mPS失活,与其激活剂lysophosphatidylserine (LysoPS) 不同. 这为开发新的癌症疗法提供了基础.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- GPR174是一种免疫受限的G蛋白结合受体 (GPCR),由溶酸胺素 (LysoPS) 激活.
- 在瘤中升高的LysoPS可以导致免疫抑制和对癌症免疫疗法的抵抗.
- 了解GPR174与配体的相互作用对于开发向癌症治疗至关重要.
研究的目的:
- 调查GPR174激活和对抗的基础分子机制.
- 为了比较GPR174与其激活剂 (LysoPS) 和对抗剂 (mPS) 的结合模式和构造动态.
- 为设计针对GPR174的新型癌症免疫疗法提供结构基础.
主要方法:
- 对GPR174结合mPS的分子建模.
- 在异质脂质双层中进行广泛的分子动力学 (MD) 模拟.
- 与LysoPS结合的GPR174.4的并行模拟.
- 网络分析和蛋白质脂质相互作用分析.
主要成果:
- mPS结合失活了GPR174,减少了构造动态,稳定了与跨膜螺旋体的相互作用 1.
- 莱索PS结合诱导了更大的形状灵活性,多重结合姿势和短暂的膜相互作用.
- 莱索PS引入保存的激活动机 (PIF,DRY,N/DPxxY) 来与G蛋白界面结合,而mPS则破坏了这些通路.
- 像PIP2这样的膜脂质被证明可以调节连接体动力学和受体结构状态.
结论:
- 通过LysoPS和mPS,不同的联体特异性机制控制了GPR174的调制.
- mPS通过破坏GPR174.4内的关键激活通路而起到有效的对抗作用.
- 这些发现为选择性GPR174抗剂的合理设计提供了框架,用于癌症免疫治疗.
相关概念视频
Transducer Mechanism: G Protein–Coupled Receptors
4.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.0K
Activation and Inactivation of G Proteins
11.0K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.0K
G Protein-coupled Receptors
16.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.6K
G-protein Coupled Receptors
131.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.6K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K


